Table 2 Cumulative discounted simulated results for the Netherlands from the healthcare perspective: years with disease, costs, QALYs gained and ICER
5 years | 10 years | 20 years | 60 years | |
|---|---|---|---|---|
AMI prevalence | − 9.12 | − 39.3 | − 121 | − 160 |
CVA prevalence | − 2.82 | − 13.7 | − 50.1 | − 72.4 |
CHF prevalence | − 1.13 | − 5.96 | − 27.7 | − 46.3 |
AMI incidence | − 5.52 | − 11.4 | − 19.4 | − 21.2 |
CVA incidence | − 1.95 | − 4.79 | − 10.6 | − 13.2 |
CHF incidence | − 0.742 | − 2.21 | − 7.01 | − 9.77 |
QALYs gained | 4.19 | 19.4 | 74.0 | 135 |
Intervention costs | ||||
Selection and invitation costs: 1200 Euro per GP practice (million Euro) | 6.00 | 6.00 | 6.00 | 6.00 |
Lifestyle + healthcare costs in the year of intervention: 132 Euro per patient (million Euro) | 34.4 | 34.4 | 34.4 | 34.4 |
Future healthcare costs (million Euro) | − 0.0316 | − 0.110 | 0.0548 | 0.984 |
Total costs (million Euro) | 40.4 | 40.3 | 40.5 | 41.4 |
ICER (million Euro/QALY) | 9.63 | 2.08 | 0.547 | 0.306 |